Academic Journals Database
Disseminating quality controlled scientific knowledge

Dramatic Response of a Case ofRecurrent Basal Cell Carcinoma toSystemic Chemotherapy

Author(s): Shapour Omidvari | Hamid Nasrolahi | Mansour Ansrai | Niloofar Ahmadloo | Ahmad Mosalaei | Mohammad Mohammadianpanah

Journal: Middle East Journal of Cancer
ISSN 2008-6709

Volume: 1;
Issue: 4;
Start page: 181;
Date: 2010;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: Basal cell carcinoma | Recurrence | Chemotherapy | Cisplatin | 5-Flourouracil

Basal cell carcinoma (BCC) is the most common cancer among humans, and the standard treatment is surgery. Other modalities are reserved as a second line of treatment. Topical chemotherapy may be used in primary BCC. Systemic chemotherapy has no role in the primary treatment of BCC, although it may be efficacious in metastatic cases. We report the case of a patient with persistent recurrent BCC following multiple surgeries and radiotherapy, who achieved a dramatic response with a cisplatinand 5-flourouracil chemotherapy regimen.
Affiliate Program      Why do you need a reservation system?